Presentation is loading. Please wait.

Presentation is loading. Please wait.

Bottom-up proteomic characterization of MALDI IMS samples.

Published bySudomo Kusumo Modified over 5 years ago

Similar presentations

Presentation on theme: "Bottom-up proteomic characterization of MALDI IMS samples."— Presentation transcript:

1 Bottom-up proteomic characterization of MALDI IMS samples.
Bottom-up proteomic characterization of MALDI IMS samples.A, protein identification summary of ten human tissues. B, cumulated number of identified proteins from the ten different tissues and three protein extractions. Samples are ordered such that the highest number of identifications is obtained for the smallest number of samples combined. C, distribution of identified proteins by molecular weight. Bins were chosen according to the marker used in the SDS-PAGE shown in Fig. 1B. Blue bars represent the distribution of entries in the Uniprot database (human only). D, distribution of proteins by cellular compartment. Stefan K. Maier et al. Mol Cell Proteomics 2013;12: © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.

Download ppt "Bottom-up proteomic characterization of MALDI IMS samples."

Similar presentations

2D PAGE/Western blotting analysis for the identification of possible post-translation modification of Hsp27 from the spinal cord tissue of the SCI rat.

2D PAGE/Western blotting analysis for the identification of possible post-translation modification of Hsp27 from the spinal cord tissue of the SCI rat.
NSAF and GeneChip data have similar distribution properties.

NSAF and GeneChip data have similar distribution properties.
Sequence alignment of C-terminal phosphorylated plant aquaporins

Sequence alignment of C-terminal phosphorylated plant aquaporins
Enrichment of sequence disorder in the cytosolic phosphoproteome.

Enrichment of sequence disorder in the cytosolic phosphoproteome.
Phosphorylation and sequence disorder in microtubule-associated protein Tau.A, schematic illustration of the domain profile of Tau with all known phosphorylation.

Phosphorylation and sequence disorder in microtubule-associated protein Tau.A, schematic illustration of the domain profile of Tau with all known phosphorylation.
Distribution of phosphorylation sites identified in the cytosolic phosphoproteome.A, numbers of approved phosphopeptides, previously phosphorylated peptides,

Distribution of phosphorylation sites identified in the cytosolic phosphoproteome.A, numbers of approved phosphopeptides, previously phosphorylated peptides,
Microvesicles released by PC-3 cells.

Microvesicles released by PC-3 cells.
Fast protein LC IMAC purification of cytosolic phosphoproteins

Fast protein LC IMAC purification of cytosolic phosphoproteins
Percentage of proteins identified in envelope membrane extracts according to the purification method and the number of transmembrane domains. Percentage.

Percentage of proteins identified in envelope membrane extracts according to the purification method and the number of transmembrane domains. Percentage.
Differential conjugation of endogenous SUMO-1 and endogenous SUMO-2/3 to target proteins.A and B, SUMO-1 and SUMO-2 proteins were produced in E coli and.

Differential conjugation of endogenous SUMO-1 and endogenous SUMO-2/3 to target proteins.A and B, SUMO-1 and SUMO-2 proteins were produced in E coli and.
Plasma CEP adducts and autoantibodies by donor age.

Plasma CEP adducts and autoantibodies by donor age.
Frequency distribution of the GRAVY of the theoretical proteins (open bars) and of 110 genes encoding proteins identified on a 2-D electrophoresis gel,

Frequency distribution of the GRAVY of the theoretical proteins (open bars) and of 110 genes encoding proteins identified on a 2-D electrophoresis gel,
Top-down protein identification.

Top-down protein identification.
Two-dimensional electrophoresis results and validation with Western blotting. Two-dimensional electrophoresis results and validation with Western blotting.

Two-dimensional electrophoresis results and validation with Western blotting. Two-dimensional electrophoresis results and validation with Western blotting.
Distributions of the ELDP values and Mascot scores for all protein identifications.a, frequency of ELDP value returned by correct (gray bars) and incorrect.

Distributions of the ELDP values and Mascot scores for all protein identifications.a, frequency of ELDP value returned by correct (gray bars) and incorrect.
Significantly enriched phosphorylation motifs from up-regulated phosphopeptides by Motif-X analysis. Significantly enriched phosphorylation motifs from.

Significantly enriched phosphorylation motifs from up-regulated phosphopeptides by Motif-X analysis. Significantly enriched phosphorylation motifs from.
Visual validation of the computational outputs.

Visual validation of the computational outputs.
Frequency distribution of the effect size measure (ESM) of sperm protein spots of type-1 diabetic (A), type-2 diabetic (B) and non-diabetic obese (C) patients.

Frequency distribution of the effect size measure (ESM) of sperm protein spots of type-1 diabetic (A), type-2 diabetic (B) and non-diabetic obese (C) patients.
Schematic representation of proteogenomic annotation strategy.

Schematic representation of proteogenomic annotation strategy.
Global visualization of antigen and epitope discovery.

Global visualization of antigen and epitope discovery.

Similar presentations

Ads by Google